NASDAQ · Biotechnology
Cassava Sciences Inc (SAVA)
$2.38
0.00%
Moving averages
SMA 200$2.52-5.56%
Company profile
Cassava Sciences, Inc., a clinical-stage biotechnology company, develops drugs for neurodegenerative diseases. The company is headquartered in Austin, Texas.
SectorHealthcare
IndustryBiotechnology
Market cap$114.97M
P/E ratioNone
EPS$-2.22
Beta-0.84
Dividend yield0.00%
52-week high$3.45
52-week low$1.20
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
IMUX
Immunic Inc
RSI 45
NERV
Minerva Neurosciences Inc
RSI 36
CHRS
Coherus Biosciences Inc
RSI 24
IVVD
Invivyd Inc
RSI 30
HRTX
Heron Therapeutics Inc
RSI 39
ARTV
Artiva Biotherapeutics Inc
RSI 23
RSI alerts for SAVA
An email when SAVA closes below RSI 30 or above 70. Nothing else.
Data last updated 31 October 2026 at 9:02 PM EDT